Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Liver Tumors
How do you approach treatment options for patients with fibrolamellar HCC compared to "normal" HCC?
Related Questions
How has the GALAD score affected your practice for HCC screening?
How does the use of checkpoint inhibitors for treatment of HCC impact timing of liver transplant and subsequent immunosuppression?
What is your evaluation approach for a new patient referral for an incidentally found liver lesion?
How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?
What is your approach to treatment of immune-mediated overlap syndromes, such as AIH-PBC?
When would you decide to pursue plasma exchange in a patient in acute liver failure due to sinusoidal obstruction syndrome?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
How do you diagnose cystic fibrosis related liver disease?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
How do you approach a patient who has incidentally found liver and renal cysts?
